Skip to Content

Fungal Meningitis Testing Information and Resources

On October 4, 2012, the Centers for Disease Control and Prevention released an official health advisory of a multistate investigation of fungal meningitis and joint infections among patients who received epidural or joint space injections of certain steroid products. As discussed in the Mayo Medical Laboratories Hot Topic: Fungal Meningitis: A Critical Problem Caused By Injection of a Contaminated Medication, a single compounding laboratory distributed contaminated steroid medications to multiple medical sites in May 2012. The primary source of these infections has been identified as preservative-free methylprednisolone acetate, prepared by the New England Compounding Center in Framingham, Mass.

Mayo Clinic Laboratories

Mayo Clinic Laboratories

This post was authored by the Marketing Team at Mayo Clinic Laboratories.